Josep M. Grinyó
About
Josep M. Grinyó is a scholar working on Transplantation, Surgery and Nephrology.
According to data from OpenAlex, Josep M. Grinyó has authored 285 papers receiving a total of 11.7k indexed citations (citations by other indexed papers that have themselves been cited), including 191 papers in Transplantation, 90 papers in Surgery and 52 papers in Nephrology. Recurrent topics in Josep M. Grinyó's work include Renal Transplantation Outcomes and Treatments (188 papers), Organ Transplantation Techniques and Outcomes (67 papers) and Pharmacological Effects and Toxicity Studies (47 papers). Josep M. Grinyó is often cited by papers focused on Renal Transplantation Outcomes and Treatments (188 papers), Organ Transplantation Techniques and Outcomes (67 papers) and Pharmacological Effects and Toxicity Studies (47 papers). Josep M. Grinyó collaborates with scholars based in Spain, United States and France. Josep M. Grinyó's co-authors include Josep M. Cruzado, Joan Torrás, Oriol Bestard, Björn Nashan, Flavio Vincenti, Henrik Ekberg, Daniel Serón, Núria Lloberas, Philip F. Halloran and Francesc Moreso and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and Blood.
In The Last Decade
Josep M. Grinyó
283 papers receiving 11.5k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Josep M. Grinyó Spain | 57 | 7.3k | 4.1k | 2.2k | 2.1k | 1.7k | 285 | 11.7k | ||
| Johan W. de Fijter Netherlands | 57 | 5.2k 0.7× | 3.4k 0.8× | 1.6k 0.7× | 2.1k 1.0× | 1.9k 1.1× | 323 | 11.1k | ||
| Flavio Vincenti United States | 66 | 9.6k 1.3× | 5.3k 1.3× | 3.6k 1.6× | 2.9k 1.4× | 2.5k 1.5× | 270 | 16.4k | ||
| Björn Nashan Germany | 55 | 5.9k 0.8× | 5.3k 1.3× | 2.7k 1.2× | 1.5k 0.7× | 602 0.4× | 377 | 12.8k | ||
| Christophe Legendre France | 76 | 9.1k 1.2× | 5.1k 1.2× | 3.6k 1.6× | 3.6k 1.7× | 4.3k 2.6× | 426 | 18.5k | ||
| Minnie Sarwal United States | 48 | 5.1k 0.7× | 3.3k 0.8× | 1.2k 0.5× | 1.6k 0.7× | 1.4k 0.8× | 251 | 9.7k | ||
| E. Steve Woodle United States | 58 | 5.2k 0.7× | 5.0k 1.2× | 1.9k 0.9× | 1.5k 0.7× | 790 0.5× | 354 | 11.6k | ||
| David N. Rush Canada | 47 | 6.4k 0.9× | 4.1k 1.0× | 1.2k 0.5× | 1.1k 0.5× | 2.1k 1.3× | 145 | 8.8k | ||
| Mark D. Stegall United States | 73 | 11.0k 1.5× | 8.5k 2.1× | 1.8k 0.8× | 2.3k 1.1× | 3.9k 2.3× | 323 | 17.5k | ||
| Hans W. Sollinger United States | 58 | 6.5k 0.9× | 7.7k 1.9× | 1.9k 0.9× | 1.4k 0.7× | 764 0.5× | 345 | 12.5k | ||
| Maarten Naesens Belgium | 55 | 5.1k 0.7× | 3.0k 0.7× | 977 0.4× | 846 0.4× | 2.1k 1.3× | 242 | 9.0k |
Countries citing papers authored by Josep M. Grinyó
Since
Specialization
Citations
This map shows the geographic impact of Josep M. Grinyó's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Josep M. Grinyó with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Josep M. Grinyó more than expected).
Fields of papers citing papers by Josep M. Grinyó
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Josep M. Grinyó. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Josep M. Grinyó. The network helps show where Josep M. Grinyó may publish in the future.
Co-authorship network of co-authors of Josep M. Grinyó
This figure shows the co-authorship network connecting the top 25 collaborators of Josep M. Grinyó. A scholar is included among the top collaborators of Josep M. Grinyó based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Josep M. Grinyó. Josep M. Grinyó is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Fontova, Pere, Anna Vidal‐Alabró, Raül Rigo‐Bonnin, et al.. (2023). The Effect of Intracellular Tacrolimus Exposure on Calcineurin Inhibition in Immediate- and Extended-Release Tacrolimus Formulations. Pharmaceutics. 15(5). 1481–1481.
2.
Fontova, Pere, Anna Vidal‐Alabró, Raül Rigo‐Bonnin, et al.. (2023). CYP3A5*3 and CYP3A4*22 Cluster Polymorphism Effects on LCP-Tac Tacrolimus Exposure: Population Pharmacokinetic Approach. Pharmaceutics. 15(12). 2699–2699.
3.
Meneghini, María, Oriol Bestard, & Josep M. Grinyó. (2021). Immunosuppressive drugs modes of action. Best Practice & Research Clinical Gastroenterology. 54-55. 101757–101757.
4.
Melilli, Edoardo, Ignacio Revuelta, María Meneghini, et al.. (2021). Adoption of a novel smart mobile‐health application technology to track chronic immunosuppression adherence in solid organ transplantation: Results of a prospective, observational, multicentre, pilot study. Clinical Transplantation. 35(5). e14278–e14278.
5.
Fontova, Pere, Raül Rigo‐Bonnin, Anna Vidal‐Alabró, et al.. (2019). Measurement of calcineurin activity in peripheral blood mononuclear cells by ultra-high performance liquid chromatography-tandem mass spectrometry. Renal transplant recipients application (pharmacodynamic monitoring). Clinica Chimica Acta. 495. 287–293.
6.
Lúcia, Marc, et al.. (2018). A multicolour HLA-specific B-cell FluoroSpot assay to functionally track circulating HLA-specific memory B cells. Journal of Immunological Methods. 462. 23–33.
7.
Glotz, Denis, Graeme Russ, Lionel Rostaing, et al.. (2015). Eculizumab In Prevention Of Acute Antibody-Mediated Rejection In Sensitized Deceased-Donor Kidney Transplant Recipients : 1-Year Outcomes. Transplant International. 28. 119–119.
8.
Lúcia, Marc, Sònia Luque, Elena Crespo, et al.. (2015). Preformed circulating HLA-specific memory B cells predict high risk of humoral rejection in kidney transplantation. Kidney International. 88(4). 874–887.
9.
Franquesa, Marcella, Joan Torrás, Èlia Ripoll, et al.. (2012). Mesenchymal Stem Cell Therapy Prevents Interstitial Fibrosis and Tubular Atrophy in a Rat Kidney Allograft Model. Stem Cells and Development. 21(17). 3125–3135.
10.
Cruzado, Josep M., Santiago Rodrı́guez de Córdoba, Edoardo Melilli, et al.. (2009). Successful Renal Transplantation in a Patient with Atypical Hemolytic Uremic Syndrome Carrying Mutations in Both Factor I and MCP. American Journal of Transplantation. 9(6). 1477–1483.
11.
Morales, J.M., Anders Hartmann, Rowan G. Walker, et al.. (2009). Similar Lipid Profile But Improved Long-Term Outcomes With Sirolimus After Cyclosporine Withdrawal Compared to Sirolimus With Continuous Cyclosporine. Transplantation Proceedings. 41(6). 2339–2344.
12.
Ekberg, Henrik, Hélio Tedesco‐Silva, A. Demirbaş, et al.. (2008). CNI sparing in de novo renal transplantation: 3-year results from the symphony study. Lund University Publications (Lund University).
13.
Serón, Daniel, Francisco O′Valle, Francesc Moreso, et al.. (2007). Immunophenotype of Infiltrating Cells in Protocol Renal Allograft Biopsies From Tacrolimus-Versus Cyclosporine-Treated Patients. Transplantation. 83(5). 649–652.
14.
Grinyó, Josep M., Henrik Ekberg, Federico Oppenheimer, et al.. (2007). Pharmacokinetics of total and free mycophenolic acid in renal transplantation receiving standard-dose cyclosporine, low-dose cyclosporine, low-dose tacrolimus or low-dose sirolimus: The symphony PK sub-study. Transplant International. 20. 177–177.
15.
Bestard, Oriol, Josep M. Cruzado, M Mestre, et al.. (2007). Achieving Donor-Specific Hyporesponsiveness Is Associated with FOXP3+ Regulatory T Cell Recruitment in Human Renal Allograft Infiltrates. The Journal of Immunology. 179(7). 4901–4909.
16.
Vincenti, Flavio, Yves Vanrenterghem, Björn Nashan, et al.. (2005). The use of mycophenolate mofetil, daclizumab and corticosteroids with cyclosporine (low dose, low dose/withdrawal and standard dose) to optimize renal function in renal allograft recipients - 18 month results. American Journal of Transplantation. 5. 539–540.
17.
Cruzado, Josep M., Teresa Casanovas-Taltavull, Joan Torrás, et al.. (2003). Pretransplant Interferon Prevents Hepatitis C Virus-Associated Glomerulonephritis in Renal Allografts by HCV-RNA Clearance. American Journal of Transplantation. 3(3). 357–360.
18.
Grinyó, Josep M., Salvador Gil‐Vernet, Josep M. Cruzado, et al.. (2003). Calcineurin inhibitor-free immunosuppression based on antithymocyte globulin and mycophenolate mofetil in cadaveric kidney transplantation: results after 5�years. Transplant International. 16(11). 820–827.
19.
Behrend, Matthias, Josep M. Grinyó, Yves Vanrenterghem, et al.. (1999). Mycophenolate mofetil in renal transplantation: 3-year results from the placebo-controlled trial. Transplantation. 68(3). 391–396.
20.
Grinyó, Josep M., et al.. (1999). Hyperacute rejection models: ex vivo xenoperfusion systems. Transplantation Proceedings. 31(1-2). 970–971.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Johan W. de Fijter Breakdown of academic impact, for papers by Flavio Vincenti Breakdown of academic impact, for papers by Björn Nashan Breakdown of academic impact, for papers by Christophe Legendre Breakdown of academic impact, for papers by Minnie Sarwal Breakdown of academic impact, for papers by E. Steve Woodle Breakdown of academic impact, for papers by David N. Rush Breakdown of academic impact, for papers by Mark D. Stegall Breakdown of academic impact, for papers by Hans W. Sollinger Breakdown of academic impact, for papers by Maarten Naesens